These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1485718)

  • 1. An immunological approach to aging.
    Doria G; Frasca D; Covelli V
    Ann N Y Acad Sci; 1992 Dec; 673():226-30. PubMed ID: 1485718
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and immunological effects of thymosin alpha 1 and its fragments on inhibitory factor in minimal change nephrotic syndrome.
    Abiko T; Onodera I; Sekino H
    Chem Pharm Bull (Tokyo); 1980 Dec; 28(12):3542-8. PubMed ID: 7226295
    [No Abstract]   [Full Text] [Related]  

  • 3. Influences of aging and dietary restriction on serum thymosin alpha 1 levels in mice.
    Weindruch R; Naylor PH; Goldstein AL; Walford RL
    J Gerontol; 1988 Mar; 43(2):B40-2. PubMed ID: 3346517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoregulation in aging.
    Doria G; Adorini L; Sabbadini E; Mancini C; Frasca D
    Ann N Y Acad Sci; 1988; 521():182-8. PubMed ID: 2897816
    [No Abstract]   [Full Text] [Related]  

  • 5. Thymalfasin: an immune system enhancer for the treatment of liver disease.
    Sjogren MH
    J Gastroenterol Hepatol; 2004 Dec; 19 Suppl 6():S69-72. PubMed ID: 15546253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of thymosin peptides on the chick chorioallantoic membrane angiogenesis model.
    Koutrafouri V; Leondiadis L; Avgoustakis K; Livaniou E; Czarnecki J; Ithakissios DS; Evangelatos GP
    Biochim Biophys Acta; 2001 Nov; 1568(1):60-6. PubMed ID: 11731086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymalfasin: an immune system enhancer for the treatment of liver disease.
    Sjogren MH
    J Gastroenterol Hepatol; 2004 Dec; 19(12):S69-72. PubMed ID: 15641207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymosin alpha 11: a peptide related to thymosin alpha 1 isolated from calf thymosin fraction 5.
    Caldarella J; Goodall GJ; Felix AM; Heimer EP; Salvin SB; Horecker BL
    Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7424-7. PubMed ID: 6369316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory peptides and the central nervous system.
    Hall NR; McGillis JP; Spangelo BL; Healy DL; Goldstein AL
    Springer Semin Immunopathol; 1985; 8(1-2):153-64. PubMed ID: 3890236
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of thymosin alpha 1 on the antitumor activity of tumor-associated macrophage-derived dendritic cells.
    Shrivastava P; Singh SM; Singh N
    J Biomed Sci; 2004; 11(5):623-30. PubMed ID: 15316138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of thymosin alpha1 on the development of amoeboid microglial cells in the corpus callosum of neonatal BALB/c and athymic mice.
    Htain WW; Leong SK; Yuen R; Ling EA
    Brain Res; 1997 Apr; 755(1):63-73. PubMed ID: 9163541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biology and chemistry of thymosin peptides. Modulators of immunity and neuroendocrine circuits.
    Spangelo BL; Hall NR; Goldstein AL
    Ann N Y Acad Sci; 1987; 496():196-204. PubMed ID: 3474970
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of synthetic thymosin beta 9 fragments on low E-rosette-forming cells of lupus nephritis patients.
    Abiko T; Sekino H
    J Appl Biochem; 1983 Dec; 5(6):446-52. PubMed ID: 6236194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of thymosin in the treatment of autoimmune diseases.
    Goldstein AL; Zatz MM; Low TL; Jacobs R
    Ann N Y Acad Sci; 1981; 377():486-95. PubMed ID: 6462093
    [No Abstract]   [Full Text] [Related]  

  • 15. Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B.
    Liaw YF
    J Gastroenterol Hepatol; 2004 Dec; 19 Suppl 6():S73-5. PubMed ID: 15546254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymalfasin for the treatment of chronic hepatitis C infection.
    Rustgi VK
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):885-92. PubMed ID: 16307501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Modulation with Thymosin Alpha 1 Treatment.
    King R; Tuthill C
    Vitam Horm; 2016; 102():151-78. PubMed ID: 27450734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of thymic peptide thymosin alpha 1 with vasoactive intestinal peptide (VIP) receptors.
    Calvo JR; Goberna R; Guerrero JM
    Biosci Rep; 1986 Aug; 6(8):727-33. PubMed ID: 3028522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymosin-like peptides are present in lung cancer cell lines.
    Moody TW
    Ann N Y Acad Sci; 1994 Oct; 739():347-9. PubMed ID: 7832494
    [No Abstract]   [Full Text] [Related]  

  • 20. A multicenter, randomized, observation-controlled clinical trial to evaluate the efficacy and safety of thymalfasin adjuvant therapy in patients with HBV-related HCC after curative resection - first announcement of the protocol.
    Qiu SJ; Zhou ZG; Shen F; Li AJ; Chen MS; Ying MG; Chen Z; Zhang YX; Sun HC; Fan J
    Expert Opin Biol Ther; 2015; 15 Suppl 1():S133-7. PubMed ID: 26094695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.